nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—Foreign body sensation in eyes—Timolol—migraine	0.0473	0.0633	CcSEcCtD
Tafluprost—Conjunctivitis allergic—Timolol—migraine	0.0473	0.0633	CcSEcCtD
Tafluprost—Erythema of eyelid—Timolol—migraine	0.0401	0.0536	CcSEcCtD
Tafluprost—Eye discharge—Timolol—migraine	0.0311	0.0416	CcSEcCtD
Tafluprost—Punctate keratitis—Timolol—migraine	0.029	0.0388	CcSEcCtD
Tafluprost—Common cold—Timolol—migraine	0.0281	0.0375	CcSEcCtD
Tafluprost—Exacerbation of asthma—Timolol—migraine	0.0281	0.0375	CcSEcCtD
Tafluprost—Iritis—Gabapentin—migraine	0.0179	0.024	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Timolol—migraine	0.0167	0.0223	CcSEcCtD
Tafluprost—PTGFR—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.0165	0.0654	CbGpPWpGaD
Tafluprost—Eye pruritus—Timolol—migraine	0.0164	0.0219	CcSEcCtD
Tafluprost—Ocular hyperaemia—Timolol—migraine	0.0156	0.0209	CcSEcCtD
Tafluprost—Conjunctival hyperaemia—Gabapentin—migraine	0.0155	0.0207	CcSEcCtD
Tafluprost—Endophthalmitis—Timolol—migraine	0.0154	0.0206	CcSEcCtD
Tafluprost—Eye pruritus—Gabapentin—migraine	0.0153	0.0204	CcSEcCtD
Tafluprost—Iritis—Topiramate—migraine	0.0151	0.0202	CcSEcCtD
Tafluprost—Eyelid oedema—Timolol—migraine	0.0145	0.0194	CcSEcCtD
Tafluprost—Visual acuity reduced—Timolol—migraine	0.0123	0.0165	CcSEcCtD
Tafluprost—Ocular hyperaemia—Topiramate—migraine	0.0122	0.0164	CcSEcCtD
Tafluprost—Endophthalmitis—Topiramate—migraine	0.0121	0.0161	CcSEcCtD
Tafluprost—Dry eye—Propranolol—migraine	0.0116	0.0156	CcSEcCtD
Tafluprost—Eyelid oedema—Topiramate—migraine	0.0114	0.0152	CcSEcCtD
Tafluprost—Visual acuity reduced—Topiramate—migraine	0.00965	0.0129	CcSEcCtD
Tafluprost—Eye irritation—Timolol—migraine	0.00858	0.0115	CcSEcCtD
Tafluprost—Lacrimation increased—Timolol—migraine	0.00795	0.0106	CcSEcCtD
Tafluprost—Photophobia—Valproic Acid—migraine	0.00772	0.0103	CcSEcCtD
Tafluprost—Cataract—Timolol—migraine	0.00769	0.0103	CcSEcCtD
Tafluprost—Dry eye—Valproic Acid—migraine	0.0076	0.0102	CcSEcCtD
Tafluprost—Lacrimation increased—Gabapentin—migraine	0.0074	0.0099	CcSEcCtD
Tafluprost—Cataract—Gabapentin—migraine	0.00716	0.00958	CcSEcCtD
Tafluprost—Photophobia—Timolol—migraine	0.00688	0.00919	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—EDNRA—migraine	0.00678	0.0269	CbGpPWpGaD
Tafluprost—Dry eye—Timolol—migraine	0.00676	0.00905	CcSEcCtD
Tafluprost—Eye pain—Valproic Acid—migraine	0.00661	0.00885	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—HTR2B—migraine	0.00647	0.0257	CbGpPWpGaD
Tafluprost—Photophobia—Gabapentin—migraine	0.0064	0.00856	CcSEcCtD
Tafluprost—Vision blurred—Amitriptyline—migraine	0.00638	0.00853	CcSEcCtD
Tafluprost—Dry eye—Gabapentin—migraine	0.0063	0.00842	CcSEcCtD
Tafluprost—Lacrimation increased—Topiramate—migraine	0.00623	0.00833	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—HTR7—migraine	0.00611	0.0242	CbGpPWpGaD
Tafluprost—Eye pain—Timolol—migraine	0.00589	0.00787	CcSEcCtD
Tafluprost—Rhinitis—Verapamil—migraine	0.00584	0.00781	CcSEcCtD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.00579	0.0229	CbGpPWpGaD
Tafluprost—Eye pain—Gabapentin—migraine	0.00548	0.00733	CcSEcCtD
Tafluprost—Photophobia—Topiramate—migraine	0.00539	0.0072	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00538	0.0213	CbGpPWpGaD
Tafluprost—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.00538	0.0213	CbGpPWpGaD
Tafluprost—Dry eye—Topiramate—migraine	0.0053	0.00709	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.005	0.0198	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—RAMP1—migraine	0.00483	0.0192	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CALCRL—migraine	0.00483	0.0192	CbGpPWpGaD
Tafluprost—Cough—Propranolol—migraine	0.00481	0.00643	CcSEcCtD
Tafluprost—Vision blurred—Verapamil—migraine	0.00478	0.00639	CcSEcCtD
Tafluprost—Nasopharyngitis—Timolol—migraine	0.00475	0.00636	CcSEcCtD
Tafluprost—Eye pain—Topiramate—migraine	0.00461	0.00617	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00461	0.0183	CbGpPWpGaD
Tafluprost—Asthma—Timolol—migraine	0.00459	0.00614	CcSEcCtD
Tafluprost—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.00449	0.0178	CbGpPWpGaD
Tafluprost—Urinary tract infection—Valproic Acid—migraine	0.00447	0.00598	CcSEcCtD
Tafluprost—Nasopharyngitis—Gabapentin—migraine	0.00443	0.00592	CcSEcCtD
Tafluprost—Nervous system disorder—Propranolol—migraine	0.00441	0.0059	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00428	0.017	CbGpPWpGaD
Tafluprost—Asthma—Gabapentin—migraine	0.00428	0.00572	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—HTR2A—migraine	0.00428	0.017	CbGpPWpGaD
Tafluprost—Rhinitis—Valproic Acid—migraine	0.00414	0.00554	CcSEcCtD
Tafluprost—Dyspnoea—Propranolol—migraine	0.00401	0.00537	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—NPS—migraine	0.004	0.0158	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—TAC1—migraine	0.004	0.0158	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—HTR2C—migraine	0.00392	0.0155	CbGpPWpGaD
Tafluprost—Pruritus—Amitriptyline—migraine	0.00391	0.00523	CcSEcCtD
Tafluprost—Eye disorder—Valproic Acid—migraine	0.00386	0.00516	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—EDNRA—migraine	0.00381	0.0151	CbGpPWpGaD
Tafluprost—Nasopharyngitis—Topiramate—migraine	0.00372	0.00498	CcSEcCtD
Tafluprost—Urinary tract infection—Gabapentin—migraine	0.00371	0.00496	CcSEcCtD
Tafluprost—Dyspnoea—Verapamil—migraine	0.00369	0.00494	CcSEcCtD
Tafluprost—Rhinitis—Timolol—migraine	0.00369	0.00493	CcSEcCtD
Tafluprost—Asthma—Topiramate—migraine	0.0036	0.00481	CcSEcCtD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00358	0.0142	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00358	0.0142	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—HTR1D—migraine	0.00351	0.0139	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00351	0.0139	CbGpPWpGaD
Tafluprost—Headache—Amitriptyline—migraine	0.00346	0.00463	CcSEcCtD
Tafluprost—Eye disorder—Timolol—migraine	0.00344	0.0046	CcSEcCtD
Tafluprost—Rhinitis—Gabapentin—migraine	0.00343	0.00459	CcSEcCtD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00341	0.0135	CbGpPWpGaD
Tafluprost—Vision blurred—Valproic Acid—migraine	0.00339	0.00453	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—HTR2B—migraine	0.00326	0.0129	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00326	0.0129	CbGpPWpGaD
Tafluprost—Eye disorder—Gabapentin—migraine	0.0032	0.00428	CcSEcCtD
Tafluprost—Cough—Valproic Acid—migraine	0.00314	0.0042	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00314	0.0124	CbGpPWpGaD
Tafluprost—Urinary tract infection—Topiramate—migraine	0.00312	0.00417	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00303	0.012	CbGpPWpGaD
Tafluprost—Vision blurred—Timolol—migraine	0.00302	0.00403	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00295	0.0117	CbGpPWpGaD
Tafluprost—Pruritus—Verapamil—migraine	0.00293	0.00392	CcSEcCtD
Tafluprost—Rhinitis—Topiramate—migraine	0.00289	0.00386	CcSEcCtD
Tafluprost—Nervous system disorder—Valproic Acid—migraine	0.00288	0.00385	CcSEcCtD
Tafluprost—Vision blurred—Gabapentin—migraine	0.00281	0.00376	CcSEcCtD
Tafluprost—Cough—Timolol—migraine	0.00279	0.00374	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00279	0.0111	CbGpPWpGaD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.00279	0.0111	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CALCRL—migraine	0.00273	0.0108	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—RAMP1—migraine	0.00273	0.0108	CbGpPWpGaD
Tafluprost—Eye disorder—Topiramate—migraine	0.00269	0.0036	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00269	0.0107	CbGpPWpGaD
Tafluprost—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.00266	0.0106	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00265	0.0105	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00265	0.0105	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00265	0.0105	CbGpPWpGaD
Tafluprost—Dyspnoea—Valproic Acid—migraine	0.00262	0.0035	CcSEcCtD
Tafluprost—Cough—Gabapentin—migraine	0.0026	0.00348	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.0026	0.0103	CbGpPWpGaD
Tafluprost—Headache—Verapamil—migraine	0.00259	0.00347	CcSEcCtD
Tafluprost—Nervous system disorder—Timolol—migraine	0.00256	0.00343	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.00253	0.01	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CALCRL—migraine	0.00248	0.00983	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—RAMP1—migraine	0.00248	0.00983	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—HTR2A—migraine	0.0024	0.00953	CbGpPWpGaD
Tafluprost—Nervous system disorder—Gabapentin—migraine	0.00239	0.00319	CcSEcCtD
Tafluprost—Vision blurred—Topiramate—migraine	0.00236	0.00316	CcSEcCtD
Tafluprost—Dyspnoea—Timolol—migraine	0.00233	0.00312	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00227	0.00902	CbGpPWpGaD
Tafluprost—Cough—Topiramate—migraine	0.00219	0.00293	CcSEcCtD
Tafluprost—Dyspnoea—Gabapentin—migraine	0.00217	0.0029	CcSEcCtD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00215	0.00853	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.00214	0.00848	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—HTR1B—migraine	0.00213	0.00843	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—TNF—migraine	0.0021	0.00834	CbGpPWpGaD
Tafluprost—Pruritus—Valproic Acid—migraine	0.00208	0.00278	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—HTR1A—migraine	0.00205	0.00812	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—TAC1—migraine	0.00202	0.00799	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—NPS—migraine	0.00202	0.00799	CbGpPWpGaD
Tafluprost—Nervous system disorder—Topiramate—migraine	0.00201	0.00268	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—HTR1D—migraine	0.00198	0.00786	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—HTR2C—migraine	0.00198	0.00784	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—EDNRA—migraine	0.00192	0.00763	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00186	0.00737	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CALCA—migraine	0.00185	0.00734	CbGpPWpGaD
Tafluprost—Pruritus—Timolol—migraine	0.00185	0.00247	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—HTR2B—migraine	0.00184	0.00731	CbGpPWpGaD
Tafluprost—Headache—Valproic Acid—migraine	0.00184	0.00246	CcSEcCtD
Tafluprost—Dyspnoea—Topiramate—migraine	0.00183	0.00244	CcSEcCtD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.0018	0.00715	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR1D—migraine	0.0018	0.00714	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—HTR7—migraine	0.00173	0.00687	CbGpPWpGaD
Tafluprost—Pruritus—Gabapentin—migraine	0.00172	0.0023	CcSEcCtD
Tafluprost—PTGFR—Signaling by GPCR—HTR2B—migraine	0.00167	0.00664	CbGpPWpGaD
Tafluprost—Headache—Timolol—migraine	0.00164	0.00219	CcSEcCtD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00159	0.00631	CbGpPWpGaD
Tafluprost—Headache—Gabapentin—migraine	0.00152	0.00204	CcSEcCtD
Tafluprost—PTGFR—Signaling Pathways—CALCRL—migraine	0.00146	0.00581	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RAMP1—migraine	0.00146	0.00581	CbGpPWpGaD
Tafluprost—Pruritus—Topiramate—migraine	0.00145	0.00194	CcSEcCtD
Tafluprost—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.00145	0.00573	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—MTHFR—migraine	0.00143	0.00568	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—BDNF—migraine	0.00134	0.00532	CbGpPWpGaD
Tafluprost—Headache—Topiramate—migraine	0.00128	0.00171	CcSEcCtD
Tafluprost—PTGFR—GPCR ligand binding—HTR2A—migraine	0.00121	0.00481	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR1B—migraine	0.0012	0.00476	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR1A—migraine	0.00116	0.00459	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—TAC1—migraine	0.00114	0.00452	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—NPS—migraine	0.00114	0.00452	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR2C—migraine	0.00112	0.00443	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR1B—migraine	0.00109	0.00433	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—EDNRA—migraine	0.00109	0.00431	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR1D—migraine	0.00106	0.00422	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR1A—migraine	0.00105	0.00417	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CALCA—migraine	0.00105	0.00415	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—migraine	0.00104	0.00411	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—TAC1—migraine	0.00103	0.0041	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—NPS—migraine	0.00103	0.0041	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR2C—migraine	0.00101	0.00402	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR2B—migraine	0.000989	0.00392	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—EDNRA—migraine	0.000987	0.00391	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR7—migraine	0.000979	0.00388	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	0.000969	0.00384	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CALCA—migraine	0.00095	0.00377	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000913	0.00362	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—FOS—migraine	0.000907	0.0036	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR7—migraine	0.000889	0.00352	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LRP1—migraine	0.000871	0.00345	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR2A—migraine	0.000685	0.00272	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000685	0.00272	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOTCH4—migraine	0.000668	0.00265	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR1B—migraine	0.000645	0.00256	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR2A—migraine	0.000622	0.00247	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR1A—migraine	0.000621	0.00246	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—migraine	0.000617	0.00245	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TAC1—migraine	0.000611	0.00242	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PGR—migraine	0.000611	0.00242	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NPS—migraine	0.000611	0.00242	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR2C—migraine	0.000599	0.00238	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EDNRA—migraine	0.000583	0.00231	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOTCH3—migraine	0.000568	0.00225	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CALCA—migraine	0.000561	0.00223	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR7—migraine	0.000525	0.00208	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—migraine	0.000488	0.00193	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFBR2—migraine	0.000452	0.00179	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CACNA1A—migraine	0.000433	0.00172	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LRP1—migraine	0.000406	0.00161	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR2A—migraine	0.000368	0.00146	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000332	0.00132	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ESR1—migraine	0.000326	0.00129	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CALCA—migraine	0.000262	0.00104	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFBR2—migraine	0.000211	0.000835	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTHFR—migraine	0.000171	0.000678	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTHFR—migraine	0.000143	0.000568	CbGpPWpGaD
